Adamas Pharmaceuticals Inc. buy tamam
Start price
13.09.17
/
50%
€18.71
Target price
13.09.18
€37.88
Performance (%)
8.97%
End price
13.09.18
€20.39
Summary
This prediction ended on 13.09.18 with a price of €20.39. The BUY prediction by tamam finished with a performance of 8.97%. tamam has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Adamas Pharmaceuticals Inc. | - | - | - | - |
| iShares Core DAX® | 0.985% | 8.314% | 7.032% | 49.791% |
| iShares Nasdaq 100 | 2.067% | 16.765% | 35.952% | 96.632% |
| iShares Nikkei 225® | 2.270% | 15.605% | 46.568% | 69.047% |
| iShares S&P 500 | 1.043% | 11.077% | 26.456% | 68.087% |
Comments by tamam for this prediction
In the thread Adamas Pharmaceuticals Inc. diskutieren
tamam stimmt der Buy-Einschätzung von klostergang zu
tamam stimmt am 13.09.2017 der Buy-Einschätzung von klostergang mit dem Kursziel 42$ zu.Überschrift: klostergang stimmt der Buy-Einschätzung von klostergang zu
(Laufzeit überschritten)
Stopped prediction by tamam for Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€3.46
17.12.19
17.12.19
€6.00
04.11.21
04.11.21
103.76%
05.11.21
05.11.21
Adamas Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€19.43
15.09.18
15.09.18
€10.00
17.12.19
17.12.19
-82.19%
17.12.19
17.12.19


